MEGAN MOORE: Open Payments
NPI 1184392839 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 36 payments from 21 companies in 2025. Trend: 2023 $496 · 2024 $818 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| Amgen Inc. | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Geron Corporation | 2 | $58 |
| Eisai Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| Celgene Corporation | 2 | $34 |
Products named: REBLOZYL, IMDELLTRA (AMG757), KEYTRUDA, DATROWAY, RYTELO, BRUKINSA, Lenvima, KISQALI.
Industry payments across NC — which companies pay providers there.
